Your session is about to expire
What is Asacol Hd
MesalazineThe Generic name of this drug
Treatment SummaryMesalazine is an anti-inflammatory drug used to treat inflammatory bowel disease. It is related to aspirin and other non-steroidal anti-inflammatory drugs. It is the active ingredient in the medication Asacol and Pentasa, which are designed to make mesalazine more stable in the body. Studies have also suggested that it may help reduce the risk of colorectal cancer.
Rowasais the brand name
Asacol Hd Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Rowasa
Mesalazine
1988
107
Approved as Treatment by the FDA
Mesalazine, otherwise called Rowasa, is approved by the FDA for 1 uses which include Crohn Disease .Crohn Disease
Effectiveness
How Asacol Hd Affects PatientsMesalazine is an active ingredient in sulphasalazine, a drug used to treat ulcerative colitis. It works by reducing inflammation, stopping the production of certain chemicals that help leukocytes move around, and acting as an antioxidant. Mesalazine is more effective when taken directly to the affected area than when taken internally. Studies have shown that it works similarly to prednisolone or sulphasalazine in reducing colitis inflammation in mice and guinea pigs.
How Asacol Hd works in the bodyThe exact way mesalazine works to treat inflammatory bowel disease is not fully known, but it likely has anti-inflammatory effects. It appears to reduce the production of substances in the colon that cause inflammation, such as prostaglandins and leukotrienes. It may also block a cell protein called Nuclear Factor kappa B, which reduces the production of pro-inflammatory cytokines. Mesalazine also may reduce the movement of white blood cells to the inflamed area, decrease the production of substances like leukotriene B4, and reduce free radical formation.
When to interrupt dosage
The proposed measure of Asacol HD depends on the distinguished condition. The dosage fluctuates as per the technique of delivery outlined in the following table.Condition
Dosage
Administration
Crohn Disease
400.0 mg, , 1200.0 mg, 800.0 mg, 400.0 mg/mL, 500.0 mg, 1000.0 mg, 375.0 mg, 250.0 mg, 10.0 mg/mL, 40.0 mg/mL, 0.4 mg/mg, 20.0 mg/mL, 200.0 mg/mL, 1000.0 mg/pump actuation, 0.2 mg/mg
Oral, Tablet, delayed release - Oral, , Tablet, delayed release, Capsule, delayed release - Oral, Capsule, delayed release, Rectal, Enema, Enema - Rectal, Kit, Tablet, Tablet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Rectal, Suppository, Suppository - Rectal, Capsule, extended release, Capsule, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Enema; Liquid, Enema; Liquid - Rectal, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Kit - Rectal
Ulcerative Colitis
400.0 mg, , 1200.0 mg, 800.0 mg, 400.0 mg/mL, 500.0 mg, 1000.0 mg, 375.0 mg, 250.0 mg, 10.0 mg/mL, 40.0 mg/mL, 0.4 mg/mg, 20.0 mg/mL, 200.0 mg/mL, 1000.0 mg/pump actuation, 0.2 mg/mg
Oral, Tablet, delayed release - Oral, , Tablet, delayed release, Capsule, delayed release - Oral, Capsule, delayed release, Rectal, Enema, Enema - Rectal, Kit, Tablet, Tablet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Rectal, Suppository, Suppository - Rectal, Capsule, extended release, Capsule, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Enema; Liquid, Enema; Liquid - Rectal, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Kit - Rectal
Proctocolitis
400.0 mg, , 1200.0 mg, 800.0 mg, 400.0 mg/mL, 500.0 mg, 1000.0 mg, 375.0 mg, 250.0 mg, 10.0 mg/mL, 40.0 mg/mL, 0.4 mg/mg, 20.0 mg/mL, 200.0 mg/mL, 1000.0 mg/pump actuation, 0.2 mg/mg
Oral, Tablet, delayed release - Oral, , Tablet, delayed release, Capsule, delayed release - Oral, Capsule, delayed release, Rectal, Enema, Enema - Rectal, Kit, Tablet, Tablet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Rectal, Suppository, Suppository - Rectal, Capsule, extended release, Capsule, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Enema; Liquid, Enema; Liquid - Rectal, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Kit - Rectal
Proctitis
400.0 mg, , 1200.0 mg, 800.0 mg, 400.0 mg/mL, 500.0 mg, 1000.0 mg, 375.0 mg, 250.0 mg, 10.0 mg/mL, 40.0 mg/mL, 0.4 mg/mg, 20.0 mg/mL, 200.0 mg/mL, 1000.0 mg/pump actuation, 0.2 mg/mg
Oral, Tablet, delayed release - Oral, , Tablet, delayed release, Capsule, delayed release - Oral, Capsule, delayed release, Rectal, Enema, Enema - Rectal, Kit, Tablet, Tablet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Rectal, Suppository, Suppository - Rectal, Capsule, extended release, Capsule, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Enema; Liquid, Enema; Liquid - Rectal, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Kit - Rectal
Colitis, Ulcerative
400.0 mg, , 1200.0 mg, 800.0 mg, 400.0 mg/mL, 500.0 mg, 1000.0 mg, 375.0 mg, 250.0 mg, 10.0 mg/mL, 40.0 mg/mL, 0.4 mg/mg, 20.0 mg/mL, 200.0 mg/mL, 1000.0 mg/pump actuation, 0.2 mg/mg
Oral, Tablet, delayed release - Oral, , Tablet, delayed release, Capsule, delayed release - Oral, Capsule, delayed release, Rectal, Enema, Enema - Rectal, Kit, Tablet, Tablet - Oral, Capsule - Oral, Capsule, Suspension, Suspension - Rectal, Suppository, Suppository - Rectal, Capsule, extended release, Capsule, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Enema; Liquid, Enema; Liquid - Rectal, Tablet, Delayed Release - Oral, Tablet, Delayed Release, Kit - Rectal
Warnings
Asacol Hd ContraindicationsCondition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Mesalazine may interact with Pulse Frequency
Common Asacol Hd Drug Interactions
Drug Name
Risk Level
Description
Macimorelin
Major
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Mesalazine.
Methotrexate
Major
The serum concentration of Methotrexate can be increased when it is combined with Mesalazine.
Mifamurtide
Major
The therapeutic efficacy of Mifamurtide can be decreased when used in combination with Mesalazine.
Neomycin
Major
The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Neomycin.
Omacetaxine mepesuccinate
Major
The risk or severity of bleeding can be increased when Mesalazine is combined with Omacetaxine mepesuccinate.
Asacol Hd Toxicity & Overdose RiskIn animal tests, up to 320mg/kg of mesalazine did not increase cancer risk, and the drug was not found to be mutagenic. It also did not affect fertility or reproduction in male and female rats. Symptoms of mesalazine toxicity include nausea, vomiting, shortness of breath, ringing in the ears, headaches, dizziness, confusion, and seizures. In the event of an overdose, there is no specific antidote but treatment may involve decontaminating the stomach and balancing fluids and electrolytes. People with impaired kidney function or a history of kidney problems should be monitored carefully while taking mesalazine.
Asacol Hd Novel Uses: Which Conditions Have a Clinical Trial Featuring Asacol Hd?
96 active clinical trials are presently evaluating the potential of Asacol Hd in providing relief for Ulcerative Colitis.Condition
Clinical Trials
Trial Phases
Proctocolitis
0 Actively Recruiting
Proctitis
0 Actively Recruiting
Crohn Disease
0 Actively Recruiting
Colitis, Ulcerative
0 Actively Recruiting
Ulcerative Colitis
0 Actively Recruiting
Asacol Hd Reviews: What are patients saying about Asacol Hd?
5Patient Review
10/26/2013 When I first started taking this medication, I got headaches. However, after talking to my doctor and making some adjustments, like changing the dose and how often I take it, that problem has gone away for the most part. Plus, I have fewer flare-ups now too!
5Patient Review
8/4/2014 I've been taking this medication for two months now, three times a day as directed. I haven't found it to be effective at all; in fact, the only thing that seems to help is staying hydrated.
5Patient Review
2/10/2016 This treatment was effective immediately.
5Patient Review
5/9/2011 I highly recommend this medication to anyone struggling with chronic pain. It's been incredibly effective for me, as long as I remember to take it regularly.
5Patient Review
12/26/2013 I am experiencing hair loss
Patient Q&A Section about asacol hd
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is Asacol HD used for?
"This medication helps to treat ulcerative colitis, which is a bowel disease. The drug works by reducing symptoms such as diarrhea, rectal bleeding, and stomach pain. Mesalamine belongs to a class of drugs known as aminosalicylates, which work by decreasing swelling in the colon."
Answered by AI
What is the difference between Asacol and Asacol HD?
"Asacol HD is a delayed-release (DR) version of mesalamine that's FDA-approved to treat moderately active UC in adults. It's available as 800 mg DR tablets. There was another brand-name product called Asacol, which was available as 400 mg DR tablets, but it is no longer on the market."
Answered by AI
Is there a generic for Asacol HD?
"The generic form of Asacol HD is mesalamine tablet, delayed release. A generic drug is an exact copy of the active drug in a brand-name medication and is considered to be as safe and effective as the original drug."
Answered by AI
What are the side effects of taking Asacol?
"The following are potential side effects of the medication: burping, constipation, nausea, vomiting, stomach pain, diarrhea, gas, dizziness, cold symptoms such as stuffy nose, sneezing, sore throat, back pain, headache, rash, or abnormal liver function tests."
Answered by AI
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.